Showing results (171-180 of 240) with videos related to
Sort By:
Pageof 24
Journal of Thrombosis and Haemostasis : JTH|June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approachJ M Kittelson, A C Spyropoulos, J L Halperin, et al.Journal of Thrombosis and Haemostasis : JTH|September 12, 2025
Perioperative use of factor concentrates and blood products-a survey of clinical practices in the United States: communication from the ISTH Subcommittee on Perioperative and Critical CareJerrold H Levy, Joseph R Shaw, Kamrouz Ghadimi, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 21, 2019
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN StudyAlex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, et al.Thrombosis and Haemostasis|May 5, 2023
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 RegistryDimitrios Giannis, Mark Goldin, Husneara Rahman, et al.Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.American Heart Journal|February 12, 2021
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD studyWarren H Capell, Elliot S Barnathan, Gregory Piazza, et al.Thrombosis and Haemostasis|January 20, 2021
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 PatientsStuart L Cohen, Eugenia Gianos, Mathew A Barish, et al.Thrombosis and Haemostasis|June 28, 2016
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillationJohn M Kittelson, Philippe Gabriel Steg, Jonathan L Halperin, et al.Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.JACC. Advances|June 28, 2024
Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients: A Cluster Randomized TrialAlex C Spyropoulos, Mark Goldin, Ioannis Koulas, et al.Pageof 24